Skip to content

Study on the effectiveness of modified GnRH agonist ultra-long protocol in patients with PCOS undering IVF/ICSI

Study on the effectiveness of modified GnRH agonist ultra-long protocol in patients with PCOS undering IVF/ICSI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16008217
Enrollment
Unknown
Registered
2016-04-05
Start date
2016-04-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility and polycystic ovary syndrome

Interventions

Improved overlong scheme group:Improved overlong scheme
antagonists group:antagonists scheme

Sponsors

Reproductive and Genetic Hospital of Citic-XiangYa
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 38 Years

Inclusion criteria

Inclusion criteria: 1. patients with PCOS accord with standard of Rotterdam 2003 for the first time to assit reproduction by IVF/ICSI; 2. age less than 38 years; 3. BMI between 18 and 28; 4. Bilateral ovaries exists and no cyst.

Exclusion criteria

Exclusion criteria: 1. patients with untreated hydrosalpinx, moderately severe endometriosis, uterine fibroids =2 cm, submucosal uterine fibroids, uterine malformation, and history of uterine cavity adhesion, etc; 2. patients with Cushing's syndrome, congenital adrenal hyperplasia, high prolactin hematic disease, high blood pressure; 3. patients need to assit reproduction by PGD or PGS; 4. patient has a history of recurrent miscarriage; 5. patients have a known history of chemotherapy or radiation therapy; 6. patients refuse or not carried out in accordance with the plan calls for treatment, including the clinical examination and laboratory examination due to any reason; 7. patients whose husband with less serious, weak, abnormal sperm disease.

Design outcomes

Primary

MeasureTime frame
live birth rate;

Countries

China

Contacts

Public ContactFei Gong

Reproductive and Genetic Hospital of Citic-XiangYa

lj_0305@126.com+86 13907485296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026